Immunogen reported $358.8M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
Amgen AMGN:US USD 63.7B 4.41B
Astellas Pharma 4503:JP JPY 2.58T 101.82B
AstraZeneca AZN:LN USD 94.18B 2.39B
Bluebird Bio BLUE:US USD 520.1M 53.49M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Eli Lilly And LLY:US USD 47.46B 397.9M
Emergent Biosolutions EBS:US USD 2.91B 173.1M
Exelixis EXEL:US USD 2.96B 79.97M
Halozyme Therapeutics HALO:US USD 1.86B 83.15M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Immunogen IMGN:US USD 358.8M 63.5M
Intrexon XON:US USD 259.24M 61.98M
Karyopharm Therapeutics KPTI:US USD 231.24M 25.24M
Macrogenics MGNX:US USD 195.35M 22.7M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Novartis NVS:US USD 118.46B 4.45B
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Seattle Genetics SGEN:US USD 3.62B 11.26M